- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07704008
The Effect of Virtual Reality Glasses Applied to Hemodialysis Patients on Vital Signs and Anxiety Level
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The research was designed and conducted as a randomized controlled experimental study to determine the effects of virtual reality glasses on the vital signs and anxiety levels of hemodialysis patients.
The study population consisted of patients diagnosed with kidney failure who received hemodialysis at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between May 2023 and May 2024. A total of 56 patients who volunteered to participate and met the inclusion criteria were included in the study. These patients were randomly assigned to two homogeneous groups according to gender and type of renal failure (acute/chronic): an experimental group (n=28) and a control group (n=28).
Patients in the experimental group watched a 4K virtual reality video featuring natural scenery accompanied by relaxing background music through virtual reality glasses during hemodialysis, whereas patients in the control group received standard hemodialysis care without any additional intervention.
Data were collected using the Patient Information Form, Vital Signs Follow-up Form, Visual Analog Scale for Pain (VAS), State Anxiety Scale, and Visual Analog Scale for Satisfaction (VAS-Satisfaction). Ethics committee approval, institutional permission, and written informed consent were obtained before the study was conducted.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Ankara, Tyrkia (Türkiye), 06200
- Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Receiving hemodialysis treatment for the first time.
- Age ≥18 years.
- No visual, hearing, or cognitive impairment.
- Able to communicate effectively.
- Clinically stable.
- No diagnosed psychiatric disorder or use of psychiatric medication.
- No history of seizures.
- Willing and able to provide informed consent.
Exclusion Criteria:
- Previous hemodialysis treatment.
- Age <18 years.
- Visual, hearing, or cognitive impairment.
- History of kidney transplantation.
- Communication difficulties.
- Diagnosed psychiatric disorder or use of psychiatric medication.
- History of seizures.
- Declined to participate in the study.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Experimental Group
Participants received a virtual reality intervention during hemodialysis in addition to standard care.
|
Participants wore virtual reality glasses at the start of the hemodialysis session and viewed a 4K nature video with calming background music for 15 minutes.
The intervention was administered once during the hemodialysis session in addition to standard hemodialysis care.
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.
|
|
Aktiv komparator: Control Group
Participants received standard hemodialysis care without any additional intervention.
|
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Systolic Blood Pressure
Tidsramme: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in systolic blood pressure measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Diastolic Blood Pressure
Tidsramme: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in diastolic blood pressure measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Heart Rate
Tidsramme: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in heart rate measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Respiratory Rate
Tidsramme: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in respiratory rate measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Peripheral Oxygen Saturation (SpO₂)
Tidsramme: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in peripheral oxygen saturation (SpO₂) measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Body Temperature
Tidsramme: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in body temperature measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
State Anxiety Level After Hemodialysis
Tidsramme: Immediately after completion of the hemodialysis session.
|
State anxiety measured using the State Anxiety Inventory (STAI-State), a 20-item questionnaire with total scores ranging from 20 to 80. Higher scores indicate greater levels of state anxiety.
Assessment was performed immediately after completion of the hemodialysis session.
|
Immediately after completion of the hemodialysis session.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Pain Score
Tidsramme: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in pain score measured using the Visual Analog Scale for Pain (VAS-P), a 0-10 scale where 0 indicates no pain and 10 indicates the worst possible pain.
Higher scores indicate greater pain.
Pain was assessed before and immediately after completion of the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Participant Satisfaction Score
Tidsramme: Immediately after completion of the hemodialysis session.
|
Participant satisfaction with the virtual reality intervention measured using the Visual Analog Scale for Satisfaction (VAS-S), a 0-10 scale where 0 indicates not satisfied at all and 10 indicates completely satisfied.
Higher scores indicate greater participant satisfaction.
Assessment was performed immediately after completion of the hemodialysis session.
|
Immediately after completion of the hemodialysis session.
|
Samarbeidspartnere og etterforskere
Etterforskere
- Studieleder: Hilal Tüzer, Assoc. Prof., Ankara Yildirim Beyazıt University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- AYBU-2023-208
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .